Future studies will aim to characterize these subsets phenotypically and functionally, determining whether memory-derived OPG+ B cells and RANKL+ T cells represent durable reservoirs of immune regulation in breast cancer. This evidence concerns the gene TNFRSF11B and breast cancer.